跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VITAMIN D3 ORAL SOLUTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VITAMIN D3 ORAL SOLUTION
Authorized
STANDARD
VITAMIN D3 ORAL SOLUTION
Galephar Pharmaceutical Research Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2ef9b76ad14d462b
Company
Galephar Pharmaceutical Research Inc
Type
Standard
Approval Details
Approval Id
2ef9b76ad14d462b
Drug Approval Canada Name
VITAMIN D3 ORAL SOLUTION
Product Name
VITAMIN D3 ORAL SOLUTION
Status
Cancelled (Unreturned Annual)
Status Date
2024-01-08
Din
02512181
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Oral
Schedule
Prescription
Ahfs
88:16.00
Atc Original
A11CC05 COLECALCIFEROL
Atc Name
a 11 cc 05
Aig Number
0108524012
Company Name
Galephar Pharmaceutical Research Inc
Company Address
Carr 925 Km 6.1 Barrio Junquitos, Humacao, --, Puerto Rico, 00792
Company Detail Path
/organization/galephar-pharmaceutical-research-inc
Company Information
Pharmaceutical Company Name
Galephar Pharmaceutical Research Inc
Country Name
United States
Province Name
Puerto Rico
City Name
humacao,puerto rico,country_us
Address
Rd 925 Km 6.1 Bo Junquito
Active Ingredients
VITAMIN D3
25000 UNIT / AMP
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2ef9b76ad14d462b
Type
Standard
Back to Health Canada Approvals